Future Of British Business
UK to Study DNA of 100,000 Newborns Looking for Rare Diseases
This article is for subscribers only.
Around 100,000 newborn babies will have their entire genome sequenced, as part of a £105 million ($128.7 million) study into whether the practice could lower the burden of rare genetic diseases in the UK.
The study, led by Genomics England in partnership with the National Health Service, will test whether sequencing is a cost-effective way of preventing and treating childhood diseases. It will be funded as part of a £175 million package of support for genetics research from the Department of Health and Social Care announced Tuesday.